Clinically, prostate cancer is typically identified through methods such as digital rectal examination, prostate-specific antigen (PSA) blood test, transrectal ultrasound (TRUS)-guided biopsy, or magnetic resonance imaging (MRI) [3]. The gene discussed is KLK3; the disease is Familial prostate cancer.